These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 30979855)
1. FSHD1 or FSHD2: That is the question: The answer: It's all just FSHD. Johnson NE; Statland JM Neurology; 2019 May; 92(19):881-882. PubMed ID: 30979855 [No Abstract] [Full Text] [Related]
2. Clinical features of facioscapulohumeral muscular dystrophy 2. de Greef JC; Lemmers RJ; Camaño P; Day JW; Sacconi S; Dunand M; van Engelen BG; Kiuru-Enari S; Padberg GW; Rosa AL; Desnuelle C; Spuler S; Tarnopolsky M; Venance SL; Frants RR; van der Maarel SM; Tawil R Neurology; 2010 Oct; 75(17):1548-54. PubMed ID: 20975055 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic hypomethylation in FSHD: it's not what you inherit, it's whether it shows. Lunt PW; Figlewicz DA Neurology; 2014 Aug; 83(8):674-5. PubMed ID: 25031285 [No Abstract] [Full Text] [Related]
5. Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2. Calandra P; Cascino I; Lemmers RJ; Galluzzi G; Teveroni E; Monforte M; Tasca G; Ricci E; Moretti F; van der Maarel SM; Deidda G J Med Genet; 2016 May; 53(5):348-55. PubMed ID: 26831754 [TBL] [Abstract][Full Text] [Related]
7. A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy. Gatica LV; Rosa AL Neuromuscul Disord; 2016 Dec; 26(12):844-852. PubMed ID: 27816329 [TBL] [Abstract][Full Text] [Related]
8. Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers. Gaillard MC; Roche S; Dion C; Tasmadjian A; Bouget G; Salort-Campana E; Vovan C; Chaix C; Broucqsault N; Morere J; Puppo F; Bartoli M; Levy N; Bernard R; Attarian S; Nguyen K; Magdinier F Neurology; 2014 Aug; 83(8):733-42. PubMed ID: 25031281 [TBL] [Abstract][Full Text] [Related]
9. Double SMCHD1 variants in FSHD2: the synergistic effect of two SMCHD1 variants on D4Z4 hypomethylation and disease penetrance in FSHD2. van den Boogaard ML; Lemmers RJ; Camaño P; van der Vliet PJ; Voermans N; van Engelen BG; Lopez de Munain A; Tapscott SJ; van der Stoep N; Tawil R; van der Maarel SM Eur J Hum Genet; 2016 Jan; 24(1):78-85. PubMed ID: 25782668 [TBL] [Abstract][Full Text] [Related]
10. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. van Overveld PG; Lemmers RJ; Sandkuijl LA; Enthoven L; Winokur ST; Bakels F; Padberg GW; van Ommen GJ; Frants RR; van der Maarel SM Nat Genet; 2003 Dec; 35(4):315-7. PubMed ID: 14634647 [TBL] [Abstract][Full Text] [Related]
11. A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4. Sasaki-Honda M; Jonouchi T; Arai M; Hotta A; Mitsuhashi S; Nishino I; Matsuda R; Sakurai H Hum Mol Genet; 2018 Dec; 27(23):4024-4035. PubMed ID: 30107443 [TBL] [Abstract][Full Text] [Related]
12. Identification of variants in the 4q35 gene FAT1 in patients with a facioscapulohumeral dystrophy-like phenotype. Puppo F; Dionnet E; Gaillard MC; Gaildrat P; Castro C; Vovan C; Bertaux K; Bernard R; Attarian S; Goto K; Nishino I; Hayashi Y; Magdinier F; Krahn M; Helmbacher F; Bartoli M; Lévy N Hum Mutat; 2015 Apr; 36(4):443-53. PubMed ID: 25615407 [TBL] [Abstract][Full Text] [Related]
13. Genotype and phenotype analysis of 43 Iranian facioscapulohumeral muscular dystrophy patients; Evidence for anticipation. Alavi A; Esmaeili S; Nafissi S; Kahrizi K; Najmabadi H Neuromuscul Disord; 2018 Apr; 28(4):303-314. PubMed ID: 29402602 [TBL] [Abstract][Full Text] [Related]
14. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing. Jones TI; Yan C; Sapp PC; McKenna-Yasek D; Kang PB; Quinn C; Salameh JS; King OD; Jones PL Clin Epigenetics; 2014; 6(1):23. PubMed ID: 25400706 [TBL] [Abstract][Full Text] [Related]